NASDAQ:KMTS Kestra Medical Technologies (KMTS) Stock Price, News & Analysis $29.98 +0.57 (+1.92%) As of 01:54 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOwnershipSEC FilingsShort Interest About Kestra Medical Technologies Stock (NASDAQ:KMTS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get KMTS alerts:Sign Up Key Stats Today's Range$29.31▼$30.1050-Day Range$22.85▼$29.4252-Week Range$17.34▼$30.10Volume182,963 shsAverage Volume348,650 shsMarket Capitalization$1.79 billionP/E RatioN/ADividend YieldN/APrice Target$29.00Consensus RatingModerate Buy Company Overview Kestra Medical Technologies, Inc. is a medical technology company focused on developing and commercializing wearable solutions for patients at risk of sudden cardiac arrest. Its primary product is the ASSURE wearable cardioverter defibrillator, a wearable device designed to continuously monitor a patient’s heart rhythm and deliver a therapeutic shock when clinically necessary. The company’s platform combines cardiac monitoring, arrhythmia detection and defibrillation capabilities in a wearable system intended for use outside the hospital. Kestra also provides related clinical support and remote monitoring capabilities to help physicians and care teams manage patients during periods of elevated cardiac risk. Kestra serves healthcare providers and patients in the United States through its cardiac-care technology and associated services. The company’s products are intended to support temporary protection and ongoing clinical oversight for individuals who may face a heightened risk of life-threatening ventricular arrhythmias.AI Generated. May Contain Errors. Read More Kestra Medical Technologies Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks23rd Percentile Overall ScoreKMTS MarketRank™: 1.126551189245 of 5 starsKestra Medical Technologies scored higher than 23% of companies evaluated by MarketBeat, and ranked 776th out of 907 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.3 / 5Analyst RatingModerate Buy Consensus RatingKestra Medical Technologies has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no strong buy ratings, 5 buy ratings, 2 hold ratings, and 1 sell rating.Upside/DownsideThe consensus price target for Kestra Medical Technologies is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageKestra Medical Technologies has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Kestra Medical Technologies' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Kestra Medical Technologies are expected to grow in the coming year, from ($2.45) to ($2.12) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Kestra Medical Technologies is -11.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Kestra Medical Technologies is -11.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioKestra Medical Technologies has a P/B Ratio of 6.73. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest0.0 / 5Short Interest LevelBearish Percentage of Shares Shorted6.08% of the float of Kestra Medical Technologies has been sold short.Short Interest Ratio / Days to CoverKestra Medical Technologies has a short interest ratio ("days to cover") of 12.29, which indicates bearish sentiment.Change versus previous monthShort interest in Kestra Medical Technologies has recently increased by 4.61%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldKestra Medical Technologies does not currently pay a dividend.Dividend GrowthKestra Medical Technologies does not have a long track record of dividend growth. News and Social Media2.8 / 5News Sentiment0.46 News SentimentKestra Medical Technologies has a news sentiment score of 0.46. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 13 news articles for Kestra Medical Technologies this week, compared to 3 articles on an average week.MarketBeat Follows2 people have added Kestra Medical Technologies to their MarketBeat watchlist in the last 30 days. Company Ownership0.9 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Kestra Medical Technologies insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $9,158,873.00 in company stock.Percentage Held by Insiders5.30% of the stock of Kestra Medical Technologies is held by insiders.Percentage Held by InstitutionsKestra Medical Technologies has minimal institutional ownership at this time.Read more about Kestra Medical Technologies' insider trading history. Receive KMTS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Kestra Medical Technologies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. KMTS Stock News HeadlinesKestra Medical Technologies, Ltd. (NASDAQ:KMTS) Stock Now Rated "Moderate Buy" by Wall Street BrokeragesOctober 27 at 2:15 AM | americanbankingnews.comComparing Kestra Medical Technologies (NASDAQ:KMTS) and ClearPoint Neuro (NASDAQ:CLPT)October 26 at 2:15 AM | americanbankingnews.comWhy tech stocks are deadAI skeptics see dot-com era warning signs, and they have a point. But the real opportunity may not be in the big tech names pouring billions into data centers. Walmart's $24 million satellite network, AMR's Sabre system, and Capital One's 36,114 pricing tests all prove the same thing: compute has always been business's biggest moat, and it's about to get cheaper than ever. Porter Stansberry says one overlooked, government-protected sector is positioned to absorb this near-free compute boom and could become the next Magnificent 7.October 27 at 1:00 AM | Porter & Company (Ad)Kestra Medical Technologies (NASDAQ:KMTS) Insider Sells 15,000 Shares of StockOctober 23, 2026 | insidertrades.comKestra Medical Technologies Insider Sold Shares Worth $443,389, According to a Recent SEC FilingOctober 22, 2026 | marketscreener.comMEvercore Initiates Coverage on Kestra Medical Technologies (NASDAQ:KMTS)October 22, 2026 | americanbankingnews.comEvercore ISI Initiates Coverage on Kestra Medical Technologies With Outperform Rating, $34 PTOctober 20, 2026 | marketscreener.comMKestra Medical Technologies (NASDAQ:KMTS) Director Raymond Cohen Sells 3,330 Shares of Company StockOctober 2, 2026 | insidertrades.comSee More Headlines KMTS Stock Analysis - Frequently Asked Questions How have KMTS shares performed this year? Kestra Medical Technologies' stock was trading at $26.52 on January 1st, 2026. Since then, KMTS shares have increased by 13.0% and is now trading at $29.96. How were Kestra Medical Technologies' earnings last quarter? Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) posted its quarterly earnings results on Monday, September, 14th. The company reported ($0.75) earnings per share for the quarter, missing analysts' consensus estimates of ($0.61) by $0.14. The business had revenue of $30.97 million for the quarter. Kestra Medical Technologies had a negative trailing twelve-month return on equity of 63.83% and a negative net margin of 140.43%. Read the conference call transcript. When did Kestra Medical Technologies IPO? Kestra Medical Technologies (KMTS) raised $178 million in an initial public offering (IPO) on Thursday, March 6th 2025. The company issued 11,882,352 shares at a price of $14.00-$16.00 per share. Who are Kestra Medical Technologies' major shareholders? Kestra Medical Technologies' top institutional shareholders include Sterling Capital Management LLC. Insiders that own company stock include Brian Daniel Webster, Traci S Umberger, Alfred J Ford Jr, Timothy P Moran, Vaseem Mahboob, Raymond W Cohen, Mary Kay Ladone, Elizabeth Kwo, Jeffrey Lawrence Schwartz, Conor Hanley and Kevin C Reilly. View institutional ownership trends. How do I buy shares of Kestra Medical Technologies? Shares of KMTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings9/14/2026Today10/27/2026Fiscal Year End4/30/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (7m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 KMTS's financial health is in the Green zone, according to TradeSmith. KMTS has been in this zone for over 7 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:KMTS Previous SymbolNASDAQ:KMTS CIK1877184 Webwww.kestramedical.com Phone(425) 279-8002FaxN/AEmployees443Year Founded2021Price Target and Rating Average Price Target for Kestra Medical Technologies$29.00 High Price Target$34.00 Low Price Target$17.00 Potential Upside/Downside-3.4%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage8 Analysts Profitability EPS (Trailing Twelve Months)($2.67) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$131.61 million Net Margins-140.43% Pretax Margin-140.14% Return on Equity-63.83% Return on Assets-44.76% Debt Debt-to-Equity Ratio0.33 Current Ratio4.69 Quick Ratio4.69 Sales & Book Value Annual Sales$95.13 million Price / Sales18.79 Cash FlowN/A Price / Cash FlowN/A Book Value$4.45 per share Price / Book6.74Miscellaneous Outstanding Shares59,560,000Free Float56,405,000Market Cap$1.79 billion OptionableN/A Beta0.51 The 7 Best High-Yield Dividend Stocks for 2027Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.Get This Free Report This page (NASDAQ:KMTS) was last updated on 10/27/2026 by MarketBeat.com Staff. From Our Partners80 Days Until America's Rare Earth Supply Chain ShiftChina controls more than 90% of global rare earth alloy production, leverage it is using to restrict exports t...The Tomorrow Investor | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredMy next big call (under $1)17,556% on KDA. 3,900% on PRE. 2,650% on OCEAN. Every single one of these was recommended to our community bef...Crypto 101 Media | SponsoredHe turned $12K into $1.65M without touching Apple or TeslaTim Sykes turned $12,415 in gift money into more than $1.65 million before graduating college, without trading...Tim Sykes | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | SponsoredWhy Gerardo Del Real says wait before buying uranium stocksGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | SponsoredFirst Look: Elon’s “Starphone”Rumors are swirling that Elon Musk is developing a new mobile device that could rival the iPhone. It's said to...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kestra Medical Technologies, Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kestra Medical Technologies With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
